Cargando…

Sinonasal Malignant Melanoma Variant: A Case Report

Sinonasal malignant melanoma (SMM) is a rare malignant tumour among head and neck cancers predominantly found in adults 60 years and above. The commonly reported symptoms for sinonasal tumour lesions are nasal obstruction and recurrent, painless epistaxis as the symptoms are non-specific and can del...

Descripción completa

Detalles Bibliográficos
Autores principales: Alqurashi, Alshema, Alsulami, Omar Ayad N, Albakrei, Mohammad O, Fadag, Rehab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454378/
https://www.ncbi.nlm.nih.gov/pubmed/36106215
http://dx.doi.org/10.7759/cureus.27813
_version_ 1784785335576690688
author Alqurashi, Alshema
Alsulami, Omar Ayad N
Albakrei, Mohammad O
Fadag, Rehab
author_facet Alqurashi, Alshema
Alsulami, Omar Ayad N
Albakrei, Mohammad O
Fadag, Rehab
author_sort Alqurashi, Alshema
collection PubMed
description Sinonasal malignant melanoma (SMM) is a rare malignant tumour among head and neck cancers predominantly found in adults 60 years and above. The commonly reported symptoms for sinonasal tumour lesions are nasal obstruction and recurrent, painless epistaxis as the symptoms are non-specific and can delay the diagnosis. Moreover, melanoma has a poor prognosis regardless of its location. We report an 86-year-old female patient presenting with recurrent, painless epistaxis from the nasal cavity. Anterior rhinoscopic examination revealed a bluish-black, bleeding mass completely obstructing the left nasal nare. Contrast-enhanced computed tomography of the nasal cavity and sinus region showed a polypoidal soft tissue attenuation with heterogeneous enhancement completely filling the left nasal cavity. The patient underwent endoscopic excision. Histopathology of the specimen showed a small, round and blue cell tumour which immunohistochemistry found to be positive for S100 and HMB 45. After surgical resection, the patient received chemotherapy and radiotherapy. Sinonasal malignant melanoma is a rare, aggressive tumour that has a very poor prognosis. Contrast-enhanced computed tomography of the nasal cavity and paranasal sinuses is the imaging modality of choice which reveals the enhancing mass. There is no optimal management strategy for SMM. Surgical resection is the first-line treatment but is limited due to the complex anatomy of the sinonasal region.
format Online
Article
Text
id pubmed-9454378
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-94543782022-09-13 Sinonasal Malignant Melanoma Variant: A Case Report Alqurashi, Alshema Alsulami, Omar Ayad N Albakrei, Mohammad O Fadag, Rehab Cureus Medical Education Sinonasal malignant melanoma (SMM) is a rare malignant tumour among head and neck cancers predominantly found in adults 60 years and above. The commonly reported symptoms for sinonasal tumour lesions are nasal obstruction and recurrent, painless epistaxis as the symptoms are non-specific and can delay the diagnosis. Moreover, melanoma has a poor prognosis regardless of its location. We report an 86-year-old female patient presenting with recurrent, painless epistaxis from the nasal cavity. Anterior rhinoscopic examination revealed a bluish-black, bleeding mass completely obstructing the left nasal nare. Contrast-enhanced computed tomography of the nasal cavity and sinus region showed a polypoidal soft tissue attenuation with heterogeneous enhancement completely filling the left nasal cavity. The patient underwent endoscopic excision. Histopathology of the specimen showed a small, round and blue cell tumour which immunohistochemistry found to be positive for S100 and HMB 45. After surgical resection, the patient received chemotherapy and radiotherapy. Sinonasal malignant melanoma is a rare, aggressive tumour that has a very poor prognosis. Contrast-enhanced computed tomography of the nasal cavity and paranasal sinuses is the imaging modality of choice which reveals the enhancing mass. There is no optimal management strategy for SMM. Surgical resection is the first-line treatment but is limited due to the complex anatomy of the sinonasal region. Cureus 2022-08-09 /pmc/articles/PMC9454378/ /pubmed/36106215 http://dx.doi.org/10.7759/cureus.27813 Text en Copyright © 2022, Alqurashi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Medical Education
Alqurashi, Alshema
Alsulami, Omar Ayad N
Albakrei, Mohammad O
Fadag, Rehab
Sinonasal Malignant Melanoma Variant: A Case Report
title Sinonasal Malignant Melanoma Variant: A Case Report
title_full Sinonasal Malignant Melanoma Variant: A Case Report
title_fullStr Sinonasal Malignant Melanoma Variant: A Case Report
title_full_unstemmed Sinonasal Malignant Melanoma Variant: A Case Report
title_short Sinonasal Malignant Melanoma Variant: A Case Report
title_sort sinonasal malignant melanoma variant: a case report
topic Medical Education
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454378/
https://www.ncbi.nlm.nih.gov/pubmed/36106215
http://dx.doi.org/10.7759/cureus.27813
work_keys_str_mv AT alqurashialshema sinonasalmalignantmelanomavariantacasereport
AT alsulamiomarayadn sinonasalmalignantmelanomavariantacasereport
AT albakreimohammado sinonasalmalignantmelanomavariantacasereport
AT fadagrehab sinonasalmalignantmelanomavariantacasereport